Clinical Trial Update: APRiCOT-P: Study of Apricoxib With Gemcitabine and Erlotinib to Treat Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating apricoxib with gemcitabine and erlotinib for advanced pancreatic cancer; the study is completed and results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Apricoxib (apricoxib)
• Gemzar (gemcitabine)
• Tarceva (erlotinib)

Snippet

Sponsor: Tragara Pharmaceuticals, Inc. | Conditions: Pancreatic Cancer, Metastatic Pancreatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2012-11-07